Setsuko Nakayama, Hiroaki Nakamura, Hiromi Hamada, Tomomi Yamazaki, Makiko Egawa, Takafumi Watanabe, Satoshi Kawaguchi, Norio Miharu, Naohiko Kuno, Takeshi Nagamatsu, Akimune Fukushima, Haruka Hamanoue, Yasuyo Kasai, Haruki Nishizawa, Mayuko Ichikawa, Daisuke Katsura, Hironori Hamada, Ayako Sanui, Lena Tashima, Akinori Ida, Nobuo Ikenoue, Akinori Miki, Yoko Okamoto, Takeshi Taketani, Reiko Neki, Yoshimasa Kamei, Naoki Hamajima, Hiromi Hayakawa, Yukie Kawano, Kosuke Kawakami, Masayuki Yamaguchi, Haruhiko Sago, Tomomi Shiga, Shinya Tairaku, Yukiko Katagiri, Osamu Samura, Tetsuya Okazaki, Akihiko Sekizawa, Naoki Yamada, Shiro Tanaka, Takahiro Yamada, Nobuhiro Suzumori, Toshitaka Tanaka, Mika Ito, Kohei Sugimoto, Shun-ichiro Izumi, Hisashi Masuyama, Shinji Kosugi, Ryuhei Kurashina, Jun Murotsuki, Keiichi Matsubara, Michihiro Kitagawa, Kiyotake Ichizuka, Hideaki Sawai, Yuko Yokohama, Masaki Ogawa, Masakatsu Sase, Yuna Sasaki, Toshiyuki Sasagawa, Hiroko Morisaki, Rumi Sasaki, Tatsuko Hirose, Sadahiko Iwamoto, Mariko Matsumoto, Atsushi Kasamatsu, Takashi Kaji, Shoko Sasaki, Kiyonori Miura, Yasuyuki Hasuo, Makoto Saito, Hisao Osada, Masayuki Endo, Kazuhisa Maeda, Masaya Hirose, Masahito Mizuuchi, Toshiyuki Kakinuma, Shinji Tanigaki, Fumiki Hirahara, and Naoaki Kuji
Aim We aimed to evaluate the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of noninvasive prenatal testing (NIPT) in high-risk pregnant women. Methods Pregnant women who underwent GeneTech NIPT, the most commonly used NIPT in Japan, between January 2015 and March 2019, at Japan NIPT Consortium medical sites were recruited for this study. The exclusion criteria were as follows: pregnant women with missing survey items, multiple pregnancy/vanishing twins, chromosomal abnormalities in the fetus other than the NIPT target disease, and nonreportable NIPT results. Sensitivity and specificity were calculated from the obtained data, and maternal age-specific PPV and NPV were estimated. Results Of the 45 504 cases, 44 263 cases fulfilling the study criteria were included. The mean maternal age and gestational weeks at the time of procedure were 38.5 years and 13.1 weeks, respectively. Sensitivities were 99.78% (95% confidence interval [95% CI]: 98.78-99.96), 99.12% (95% CI: 96.83-99.76), and 100% (95% CI: 88.30-100) for trisomies 21, 18, and 13, respectively. Specificities were more than 99.9% for trisomies 21, 18, and 13, respectively. Maternal age-specific PPVs were more than 93%, 77%, and 43% at the age of 35 years for trisomies 21, 18, and 13, respectively. Conclusion The GeneTech NIPT data showed high sensitivity and specificity in the detection of fetal trisomies 21, 18, and 13 in high-risk pregnant women, and maternal age-specific PPVs were obtained. These results could provide more accurate and improved information regarding NIPT for genetic counseling in Japan.